MDS expert, Dr Stephen Nimer, provides an overview of the factors that may increase the risk of developing myelodysplastic syndromes (MDS), including: age, previous chemotherapy, high doses of radiation, and long-term exposure to certain chemicals. In rare cases, genetic changes may increase a person’s risk of developing MDS.
Share with family and friends:
Click here to take our SURVEY Your feedback is important to us! We will use your feedback to develop future areas of content about AML which will help other patients, caregivers and families.
This educational activity has been developed by the Myelodysplastic Syndromes Foundation, Inc. and Mechanisms in Medicine Inc.
This activity is supported by an educational grant from Acceleron Pharma, Celgene Corporation, Jazz Pharmaceuticals, Novartis, and Takeda Oncology.
This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.